Latest Breaking News On - India central drugs standards control organisation - Page 1 : comparemela.com

Eyestem to initiate human trials for its formulation to treat eye disorder - News Healthcare

Eyestem to initiate human trials for its formulation to treat eye disorder - News Healthcare
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Vishal lathwalRajani battuRajarshi palJogin desaiIndia central drugs standards control organisationCentral drugs standards control organisationChief executive officerAutism awareness dayChief scientistChief medical officer

Eyestem to begin human trials for its pioneering Dry AMD treatment

Dry AMD, a leading cause of vision loss in the ageing population of people over 50, has long been a challenge due to the limited availability of effective treatments and the high costs associated with emerging therapeutic options.

Andhra pradeshJogin desaiGert hooglandGullapallin raoNitin deshmukhRajani battuRajarshi palLv prasad eye instituteIndia central drugs standards control organisationCentral drugs standards control organisationChief executive officerPrasad eye institutePrivate equityKotak alternativeChief scientistChief medical officer

Eyestem to start human trials for pioneering dry AMD treatment

Eyestem to start human trials for pioneering dry AMD treatment
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Rajani battuIndia central drugs standards control organisationCentral drugs standards control organisationChief medical officer

Omicron: New lines of treatment

Antibody cocktails cut down the risk of hospital stay during Delta, but their efficacy against Omicron is uncertain - Issue Date: Jan 24, 2022

City ofUnited kingdomRahul panditSun pharmaNaresh trehanBalram bhargavaIndia central drugs standards control organisationDr reddy labsMedanta the medicityCentral drugs standards control organisationFortis hospitalsSan francisco based vir biotechnologyBeijing based beigeneDrugs controller generalCovid 19Reatments issue date jan 24

Behind the antibody cocktail rush in India s Covid-19 wave, profits for hospitals and pharma firms

On December 16, Regeneron said its cocktail drug had diminished potency against Omicron. But 13 days later, Cipla held a webinar to promote its use in India.

United statesUnited kingdomAnant waibaseSanjay nagralEli lillyJaideep gogtayMahadev waibaseSudhakar shindeRegeneron regenAltaf khanIndia central drugs standards control organisationNational institute of healthIndian council of medical researchNational health serviceWorld health organisation onNavi mumbai